Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition

Dorairaj Prabhakaran1, Shuchi Anand2, David Watkins3

  • 1Public Health Foundation of India, Gurgaon, India; Centre for Chronic Disease Control, New Delhi, India; Department of Non-communicable Disease Epidemiology, London School of Hygiene Tropical Medicine, London, UK; Rollins School of Public Health, Emory University, Atlanta, GA, USA.

Lancet (London, England)
|November 8, 2017
PubMed

Insights

Cardiovascular, respiratory, and related disorders (CVRDs) are leading global causes of death. This study outlines a cost-effective intervention package to reduce CVRD mortality, particularly in low- and middle-income countries.

Area of Science:

  • Public Health
  • Global Health
  • Preventive Medicine

Background:

  • Cardiovascular, respiratory, and related disorders (CVRDs) are the primary cause of adult mortality globally.
  • Significant disparities in CVRD care exist between high-income and low- and middle-income countries (LMICs).
  • Achieving the UN Sustainable Development Goal of reducing premature CVRD mortality by one-third by 2030 is a challenge for many LMICs.

Purpose of the Study:

  • To identify priority interventions for reducing CVRD risk and managing the conditions.
  • To present a costed essential package of interventions for CVRDs.
  • To provide a pathway for LMICs to achieve Sustainable Development Goals related to CVRDs.

Main Methods:

  • Systematic literature reviews on the effectiveness and cost-effectiveness of interventions.
  • Analysis of population-level policy interventions.
  • Assessment of primary health service strengthening strategies.

Main Results:

  • Recommended population-level interventions include tobacco taxation, trans fat bans, and salt reduction in processed foods.
  • Strengthening primary health services involves developing local guidelines and ensuring essential medication availability.
  • The proposed essential package is estimated to cost an additional US$21-24 per person in LMICs.

Conclusions:

  • The suggested policy and health service package can serve as a cornerstone for CVRD management and financial risk protection.
  • This essential package can guide LMICs in developing universal health coverage.
  • Phased implementation allows countries to align interventions with disease burden and budget constraints.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
741
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
385
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.9K
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
15.0K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
393
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K